We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Progress in Stem Cell Therapy for Transplant, Stroke and ARDS Patients
Industry Insight

Technology Networks spoke with Gil Van Bokkelen, CEO of Athersys, to learn more about MultiStem and the main mechanisms of action the cells have on the body. Gil also discussed some of the additional indications that the cells are being investigated as potential therapies for, including ischemic stroke and acute respiratory distress syndrome (ARDS).

Read More

Transforming Antibody Detection
Industry Insight

Technology Networks recently spoke with Bryan Witherbee, CEO, Ardaza, to learn more about ZIVA, a multiplex label-free biosensor platform, and discuss some of the applications it could benefit.

Read More

Exploring the Use of Plasma Viscosity Testing in Diagnosing COVID-19 Severity
Industry Insight

To learn more about plasma viscosity and how it can be measured, as well as understand how this information could potentially be used to help diagnose and treat COVID-19 patients, Technology Networks spoke with Bernie Benson, MD of Benson Viscometers.

Read More

CRISPR: Tips and Tricks for Efficient Delivery Into Primary Cells and Cell Lines
Industry Insight

This article provides tips and tricks for efficient delivery of CRISPR genome editing technology into primary cells and cell lines.

Read More

"Technology Dance" Looks Set To Transform the Field of DNA Synthesis
Industry Insight

Codexis and Molecular Assemblies recently announced a partnership through which the companies aim to engineer enzymes that will optimize the process of enzymatic DNA synthesis – an alternative approach to chemical DNA synthesis. Technology Networks spoke with Codexis to find out how this will transform the field of DNA synthesis.

Read More

Decoding the Immune System
Industry Insight

Our immune system is incredibly complex. Developing a complete understanding is an enormous undertaking but one to which scientists have been striving in order to advance disease understanding and improve treatments.

Read More

Developing Synthetic Antibiotics Against Drug-Resistant Pathogens
Industry Insight

Technology Networks spoke with James Graham, Executive Director at Recce Pharmaceuticals, to learn more about how synthetic antibiotics differ from those derived from natural sources. He also discusses how the company has developed a novel class of synthetic antibiotics and elaborates on their mechanism of action.

Read More

Exploring the Future of Lab Informatics Tools
Industry Insight

Lab-based informatics systems, such as LIMS and ELNs, are becoming more commonly used in labs. We spoke with Jeff Carter, co-founder and COO of lab software company Arxspan, to discover how COVID-19 has helped drive digitization and how tools are developing to become more flexible and connected.

Read More

Driving Drug Discovery Success With Synthetic Biology and NGS
Industry Insight

Technology Networks recently spoke with David Younger, PhD, Co-founder and CEO of A-Alpha Bio, to learn more about how the company has harnessed synthetic biology and next-generation sequencing techniques to measure millions of interactions between proteins in a single test tube. This enables the identification of potential drugs for the treatment of infectious diseases, including COVID-19.

Read More

Moderna's COVID-19 Vaccine Shows Positive Interim Results in Phase I Trial
Industry Insight

One of the COVID-19 vaccine candidates that received fast track designation by the FDA is mRNA-1273, developed by Moderna, a clinical stage biotechnology company. The company has shared the positive interim results from a Phase I clinical trial of the vaccine in The New England Journal of Medicine .

Read More

 
Advertisement